Clinical Trials Directory

Trials / Completed

CompletedNCT00882817

Pulmonary Rehabilitation in Interstitial Lung Diseases

Effects of Pulmonary Rehabilitation in Interstitial Lung Diseases: a Prospective Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Treatment in interstitial lung diseases (ILD) is frequently ineffective. Pulmonary rehabilitation (PR) is an excellent therapeutic option in another chronic lung diseases such as chronic obstructive pulmonary disease (COPD). This prospective randomized controlled study aims to evaluate the short and long-term effects of PR in patients with ILD. For this purpose, 60 ILD patients will be randomly assigned to a PR or a control group. The investigators hypothesize that PR will improve exercise capacity, increase muscle force, reduce dyspnea and improve quality of life and daily life activities in ILD patients.

Conditions

Interventions

TypeNameDescription
OTHERPulmonary RehabilitationThe intervention group will perform a 6 month pulmonary rehabilitation program which consists of training, patient education, nutrition counseling and psychosocial support. They will be evaluated with some tests for the study.

Timeline

Start date
2009-04-01
Primary completion
2011-10-01
Completion
2011-11-01
First posted
2009-04-17
Last updated
2013-08-01

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00882817. Inclusion in this directory is not an endorsement.

Pulmonary Rehabilitation in Interstitial Lung Diseases (NCT00882817) · Clinical Trials Directory